A joint venture established by Sanofi and Google parent Alphabet will combine medicines, devices and software into an extensive diabetes care product line, according to the head of the French drug maker’s global diabetes franchise.
Sanofi Joins Google’s Verily In Diabetes Venture
Sanofi’s diabetes head says French drug maker’s joint-venture pact with Google’s Verily will combine novel therapies for the condition with cutting edge technologies to produce better focused, outcome-based combinations.
